First osteoporosis drug of its kind for more than a decade approved for NHS use

A health watchdog has approved the first new osteoporosis drug of its kind for more than a decade, after medics urged it to perform a U-turn.

Earlier this year, more than 100 experts wrote a letter calling on the National Institute for Health and Care Excellence (Nice) to repeal its verdict that romosozumab should not be given on the NHS.